IN THE UNITED STATES, HOSPITAL ACQUIRED INFECTIONS (HAIs) ARE RESPONSIBLE FOR MORE DEATHS EVERY YEAR THAN AIDS, BREAST CANCER, AND LEUKEMIA COMBINED*.

HAIs are infections acquired by patients during the course of receiving care for another condition.

These infections, such as MRSA and C. diff, can be devastating and even deadly: current CDC statistics show that in the United States, 1 in every 25 patients will contract a hospital acquired infection (HAI) costing upwards of $30 billion annually, with close to 75,000 patients dying. Recent studies have demonstrated that on average, only about 50% of high-touch surfaces are cleaned as a result of a manual clean. Even after cleaning, it was found 71% of VRE occupied rooms and 78% of C. diff occupied rooms still tested positive for VRE or C. diff. Even after four rounds of disinfection with disinfectants, 25% of rooms were still contaminated with MRSA and Acinetobacter**.

Proven effective against C. diff, MRSA and 22+ other pathogens.

The Xenex mission is to eliminate harmful bacteria, viruses and spores that can cause hospital acquired infections, and to become the new standard method for disinfection in healthcare facilities worldwide. Used in nearly 300 hospitals across the United States, published peer reviewed studies confirm that Xenex Germ-Zapping Robots™ can reduce the occurrence of HAIs.

Peer reviewed published results after using Xenex:

1. 53% reduction in C. diff infection rates.
2. 57% reduction in MRSA infection rates.
3. 100% elimination of VRE in isolation rooms.

XENEX FACES OF CHANGE

Read testimonies from Xenex customers who have joined the fight against deadly HAIs by implementing Xenex Germ-Zapping Robots™ in their facilities.

1. Levin J, et al., Cooley Dickinson in AJIC 2013, 41:746-748. 2. Simmons S, et al., Cone Health System in JIP 2013. 3. Stibich M, et al., M.D. Anderson Cancer Center in ICHE 2011, 32:286-288. 
*Source: CDC http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf **Sources: Carling  PC. Infection Control and Hospital Epidemiology. 29(1), 1-7. Eckstein BC. BMC Infectious Diseases, 7, 61. doi: 1471-2334-7-61. Manian F. ICHE, 32(7), 67-72.

SIGN UP FOR OUR NEWSLETTER

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(